Vous êtes sur la page 1sur 3

USP Dissolution Test Apparatus II (Paddle) 1/31/2018 3:55

Group Members:
Capsule Formulation:
Tablet Formulation: 500 mg Acetaminophen Tablets

Analyte: Acetaminophen
Capsule Dose: 999 mg
Tablet Dose: 999 mg
Wavelength: 999 nm
Calibration Curve Parameters:
Slope: 999 (Enter the slope from the calibration curve here)
Intercept: 999 (Enter the intercept from the calibration curve here)
Assay Dilution Factor: 50 X (Dilution factor: 1:50)
V Dissolution Medium: 500 mL

Time Drug Concentration Amount Released % Released Similarity


OD999 OD999 (mg/L) (mg) (mg) Factors
(min) Capsule Tablet Capsule Tablet Capsule Tablet Capsule Tablet f1 f2
999 999.0000 999.0000 0.0000 0.0000 0.0000 0.0000 0.0 0.0 0.00 0.00
999 999.0000 999.0000 0.0000 0.0000 0.0000 0.0000 0.0 0.0 0.00 0.00
999 999.0000 999.0000 0.0000 0.0000 0.0000 0.0000 0.0 0.0 0.00 0.00
999 999.0000 999.0000 0.0000 0.0000 0.0000 0.0000 0.0 0.0 0.00 0.00
999 999.0000 999.0000 0.0000 0.0000 0.0000 0.0000 0.0 0.0 0.00 0.00
999 999.0000 999.0000 0.0000 0.0000 0.0000 0.0000 0.0 0.0 0.00 0.00
999 999.0000 999.0000 0.0000 0.0000 0.0000 0.0000 0.0 0.0 0.00 0.00

Absorbance vs. Time Concentration vs. Time


Acetaminophen Acetaminophen
1200.0000 1.0000
0.9000
Concentration (mg/L)

1000.0000 0.8000
0.7000
OD999

800.0000
0.6000
600.0000 0.5000
0.4000
400.0000 Capsule 0.3000 Capsule
Tablet 0.2000 Tablet
200.0000
0.1000
0.0000 0.0000
800 1000 1200 Time (min) 1600
1400 1800 2000 800 1000 1200 Time 1400
(min) 1600 1800 2000
A m ount R e leas ed (m g)

Dissolution Curve:
% Released vs. Time
1.0 Acetaminophen
% Released

Amount Released vs. Time 0.9


Acetaminophen
1.0000 0.8
0.9000
0.7
0.8000
0.6
0.7000
0.6000 0.5
0.5000 0.4
0.4000 0.3 Capsule
0.3000 Capsule 0.2 Tablet
0.2000 Tablet
0.1
0.1000
0.0
0.0000
800 1000 1200Time 1400
(min) 1600 1800 2000 800 1000 1200 Time (min)
1400 1600 1800 2000

f1: #DIV/0! (PASS: 0-15)


f2: 100.00 (PASS: 50-100)
#DIV/0!
Source: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm07023
oryInformation/Guidances/ucm070237.pdf

Vous aimerez peut-être aussi